Aspen Lung Conference is located in Parker, CO. The organization was established in 2002. According to its NTEE Classification (H45) the organization is classified as: Lung Diseases Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Aspen Lung Conference is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Aspen Lung Conference generated $248.5k in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 2.7% each year. All expenses for the organization totaled $230.0k during the year ending 12/2022. While expenses have increased by 3.5% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
RESEARCH IN PULMONARY MEDICINE
Describe the Organization's Program Activity:
Part 3 - Line 4a
TO PROVIDE AN INTERNATIONAL FORUM FOR LEADING CLINICIANS AND RESEARCHERS TO EXCHANGE IDEAS RELATING TO CLINICAL PROBLEMS AND RESEARCH OF THE LUNG.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Jeanne Cleary Administrator | Trustee | 20 | $40,000 |
David Riches MD Chairman | OfficerTrustee | 3 | $0 |
York Miller MD Secretary | OfficerTrustee | 3 | $0 |
Richard Martin MD Vice Chairman | OfficerTrustee | 3 | $0 |
Lisa A Maier MD Director | OfficerTrustee | 2 | $0 |
Marvin Schwarz MD Director | Trustee | 3 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $95,000 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $95,000 |
Total Program Service Revenue | $0 |
Investment income | $41,096 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $112,381 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $248,477 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $40,000 |
Compensation of current officers, directors, key employees. | $40,000 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $3,060 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $2,710 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $22,920 |
Fees for services: Other | $0 |
Advertising and promotion | $1,200 |
Office expenses | $0 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $3,000 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $46,985 |
Interest | $2,349 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $2,497 |
All other expenses | $101,933 |
Total functional expenses | $229,991 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $193,397 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $2,408,355 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $2,601,752 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $2,601,752 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $2,601,752 |
Over the last fiscal year, we have identified 2 grants that Aspen Lung Conference has recieved totaling $30,000.
Awarding Organization | Amount |
---|---|
Cardiovascular Medical Research And Education Fund Inc Philadelphia, PA PURPOSE: EXPLORE THE COMMON MECHANISMS FOUND IN NEOPLASIA PH, WITH THE OVERALL GOAL OF TRANSLATING UNDERSTANDING IN CELLULAR METABOLISM, PROLIFERATION AND SIGNALING INTO MORE EFFECTIVE THERAPIES FOR PATIENTS WITH PH. | $25,000 |
Team Phenomenal Hope Inc Beloit, WI PURPOSE: DONATION WAS FOR A 4-DAY MEDICAL CONFERENCE FOR PHYSICIANS. THE THEME WAS "EXPLORING NEW THERAPEUTIC PATHWAYS IN PULMONARY HYPERTENSION: METABOLISM PROLIFERATION AND PERSONALIZED MEDICINE". | $5,000 |
Organization Name | Assets | Revenue |
---|---|---|
Translational Genomics Research Institute Phoenix, AZ | $224,233,974 | $175,687,790 |
J David Gladstone Institutes San Francisco, CA | $318,407,379 | $84,274,665 |
Oklahoma Medical Research Foundation Oklahoma City, OK | $499,810,540 | $126,016,814 |
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Torrance, CA | $198,389,340 | $88,849,610 |
Stowers Institute For Medical Research Kansas City, MO | $238,524,295 | $116,367,619 |
Wellcome Leap Inc Culver City, CA | $553,318,259 | $346,259,833 |
La Jolla Institute For Immunology La Jolla, CA | $60,537,089 | $80,623,646 |
Lovelace Biomedical Research Institute Albuquerque, NM | $189,542,168 | $89,255,628 |
Chan Zuckerberg Biohub Inc San Francisco, CA | $338,316,919 | $10,314,755 |
Texas Biomedical Research Institute San Antonio, TX | $256,689,852 | $72,880,870 |
Baylor Research Institute Dallas, TX | $167,191,620 | $77,117,798 |
Dean Mcgee Eye Institute Oklahoma City, OK | $54,603,133 | $49,025,501 |